Group 2, Presentation 1 - Depression

Group 3, Presentation 1 - Next Generation Sequencing

Group 4, Presentation 1 - Synthetic antibody mimics

Group 5, Presentation 1 - Type 1 Diabetes

Group 1, Presentation 2 - Schizophrenia

Group 2, Presentation 2 - Migraines

Group 3, Presentation 2 - Oncolytic immunotherapy

Group 4, Presentation 2 - Yellow fever

Group 5, Presentation 2 - Chronic Myeloid Leukemia

Group 1, Presentation 3 - Atrial Fibrillation

Group 2, Presentation 3 - ALS

Group 3, Presentation 3 - Sleep Deprivation

Group 4, Presentation 3 - Alzheimer's disease

Group 5, Presentation 3 - Asthma